Indeed, since the DN activity of mutant p53 was unable to prevent wild-type p53 tumor suppression in lung tumors in vivo, our data show that wild-type p53 restoration and activation strategies should be equally effective on p53-null and mutant tumors independently of the p53 mutation present. This evidence concerns the gene TP53 and neoplasm.